Rapid and efficient production of functional Cytochrome P450 enzymatic complex fo
快速高效生产功能性细胞色素 P450 酶复合物
基本信息
- 批准号:8520339
- 负责人:
- 金额:$ 28.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:Binding ProteinsBiochemicalBiologicalBiological ModelsCell membraneCell physiologyCellsCircular DichroismComplexCytochrome P450CytochromesDetergentsDevelopmentDiseaseDrug TargetingEligibility DeterminationEnvironmentEnzymesEscherichia coliFluorescence Resonance Energy TransferGoalsHuman GenomeIndividualInvestigationLabelLengthLipid BilayersMeasurementMembraneMembrane ProteinsMicellesMolecular ConformationNMR SpectroscopyOryctolagus cuniculusOutcomeOutcome StudyOxidation-ReductionOxidoreductasePatternPhasePhysiological ProcessesPolymersPreparationProcessProductionPropertyProteinsResearchResolutionSamplingSignal TransductionSiteSolutionsSpin LabelsStructureTechniquesTestingTransmembrane DomainWaterWorkX-Ray Crystallographydrug developmentexperienceinsightmembrane modelmimeticsmutantnovelprotein complexprotein foldingpublic health relevancereconstitutionresearch studyscreeningsolid state nuclear magnetic resonancestructural biologysurfactant
项目摘要
DESCRIPTION (provided by applicant): Membrane proteins are essential regulators of a number of cellular and physiological processes including signaling between cells, transport across cell membranes and energy transduction processes. High-resolution structures of membrane proteins can provide insight into their function and enable the development of compounds to alter their properties for biological and biomedical purposes. While more than 30% of the human genome and 50% of known drug targets are membrane proteins, few structures of membrane proteins are known. For most membrane proteins, this is due to the lack of membrane mimetics that contain the protein in a stable, functional, and homogeneous state. In this application, we propose to develop robust approaches to produce near-native model membranes that both stabilize membrane-bound proteins or protein-protein complexes in their functional forms and will also enable structure determination at high-resolution by NMR spectroscopy. We have chosen cytochrome proteins (CytP450, CytP450-reductase (CYPOR) and Cytb5) and their complexes (P450-CYPOR and P450- b5) as model systems for optimization. Challenges posed by these membrane proteins are manifold and therefore the biochemical and biophysical approaches developed to tackle these challenges can be relatively easily extended for structural studies of other membrane proteins. To accomplish this goal, we propose to investigate new classes of mild detergents and non-detergent surfactants as well as native membrane-like bicelles that show promise in stabilizing the native fold of membrane proteins using a rapid assignment-free screening process by NMR spectroscopy. While the focus of this proposal is on the rapid optimization of sample conditions for NMR structural studies, the outcome can be extended for investigations using a variety of other biophysical techniques including EPR, FRET and X-ray crystallography.
PUBLIC HEALTH RELEVANCE: The outcome of the proposed studies on the production and optimization of membrane proteins will significantly advance our ability to obtain structural and functional insights at atomic-level resolution and will aid in the development of drugs to treat various diseases.
描述(由申请人提供):膜蛋白是许多细胞和生理过程的重要调节剂,包括细胞间的信号传导、跨细胞膜的运输和能量转导过程。膜蛋白的高分辨率结构可以深入了解其功能,并能够开发化合物来改变其特性,用于生物学和生物医学目的。虽然超过 30% 的人类基因组和 50% 的已知药物靶标是膜蛋白,但膜蛋白的结构知之甚少。对于大多数膜蛋白来说,这是由于缺乏含有稳定、功能性和均质状态的蛋白质的膜模拟物。在此应用中,我们建议开发稳健的方法来生产近乎天然的模型膜,既可以稳定膜结合蛋白或蛋白-蛋白复合物的功能形式,又可以通过核磁共振波谱进行高分辨率结构测定。我们选择细胞色素蛋白(CytP450、CytP450-还原酶(CYPOR)和 Cytb5)及其复合物(P450-CYPOR 和 P450-b5)作为优化的模型系统。这些膜蛋白带来的挑战是多方面的,因此为解决这些挑战而开发的生化和生物物理方法可以相对容易地扩展到其他膜蛋白的结构研究。为了实现这一目标,我们建议研究新型温和去污剂和非去污剂表面活性剂以及天然膜状双分子,它们在使用核磁共振波谱快速无分配筛选过程稳定膜蛋白的天然折叠方面表现出希望。虽然该提案的重点是快速优化 NMR 结构研究的样品条件,但结果可以扩展到使用各种其他生物物理技术(包括 EPR、FRET 和 X 射线晶体学)的研究。
公共健康相关性:拟议的膜蛋白生产和优化研究的结果将显着提高我们在原子水平分辨率上获得结构和功能见解的能力,并将有助于开发治疗各种疾病的药物。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.
一种小分子,对铜- 与锌-淀粉样蛋白-β 表现出明显的反应性,与阿尔茨海默病有关。
- DOI:10.1039/c3cc48473d
- 发表时间:2014-05-25
- 期刊:
- 影响因子:4.9
- 作者:Savelieff MG;Liu Y;Senthamarai RR;Korshavn KJ;Lee HJ;Ramamoorthy A;Lim MH
- 通讯作者:Lim MH
Two-step mechanism of membrane disruption by Aýý through membrane fragmentation and pore formation.
A××通过膜破碎和孔形成来破坏膜的两步机制。
- DOI:
- 发表时间:2012-08-22
- 期刊:
- 影响因子:3.4
- 作者:Sciacca, Michele F M;Kotler, Samuel A;Brender, Jeffrey R;Chen, Jennifer;Lee, Dong;Ramamoorthy, Ayyalusamy
- 通讯作者:Ramamoorthy, Ayyalusamy
Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation.
磷脂酰乙醇胺增强淀粉样蛋白纤维依赖性膜破碎。
- DOI:10.1021/bi3009888
- 发表时间:2012-10-02
- 期刊:
- 影响因子:2.9
- 作者:Sciacca MF;Brender JR;Lee DK;Ramamoorthy A
- 通讯作者:Ramamoorthy A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ayyalusamy Ramamoorthy其他文献
Ayyalusamy Ramamoorthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ayyalusamy Ramamoorthy', 18)}}的其他基金
Structural Investigation of Amylin Oligomers Associated to Type-2 Diabetes
与 2 型糖尿病相关的胰淀素寡聚物的结构研究
- 批准号:
10418055 - 财政年份:2022
- 资助金额:
$ 28.81万 - 项目类别:
Development of biophysical approaches to investigate high-resolution structure and dynamics of membrane proteins
开发生物物理方法来研究膜蛋白的高分辨率结构和动力学
- 批准号:
10321560 - 财政年份:2021
- 资助金额:
$ 28.81万 - 项目类别:
Membrane interaction and disruption by the Alzheimer's amyloid-beta peptide
阿尔茨海默氏症淀粉样蛋白-β 肽对膜的相互作用和破坏
- 批准号:
9321902 - 财政年份:2016
- 资助金额:
$ 28.81万 - 项目类别:
Membrane interaction and disruption by the Alzheimer's amyloid-beta peptide
阿尔茨海默氏症淀粉样蛋白-β 肽对膜的相互作用和破坏
- 批准号:
9896738 - 财政年份:2016
- 资助金额:
$ 28.81万 - 项目类别:
Rapid and efficient production of functional Cytochrome P450 enzymatic complex fo
快速高效生产功能性细胞色素 P450 酶复合物
- 批准号:
8330986 - 财政年份:2010
- 资助金额:
$ 28.81万 - 项目类别:
Rapid and efficient production of functional Cytochrome P450 enzymatic complex fo
快速高效生产功能性细胞色素 P450 酶复合物
- 批准号:
8150358 - 财政年份:2010
- 资助金额:
$ 28.81万 - 项目类别:
Rapid and efficient production of functional Cytochrome P450 enzymatic complex fo
快速高效生产功能性细胞色素 P450 酶复合物
- 批准号:
8309974 - 财政年份:2010
- 资助金额:
$ 28.81万 - 项目类别:
Rapid and efficient production of functional Cytochrome P450 enzymatic complex fo
快速高效生产功能性细胞色素 P450 酶复合物
- 批准号:
8028150 - 财政年份:2010
- 资助金额:
$ 28.81万 - 项目类别:
Membrane Interaction and Membrane Mediated Aggregation of Amylin
膜相互作用和膜介导的胰淀素聚集
- 批准号:
7748945 - 财政年份:2009
- 资助金额:
$ 28.81万 - 项目类别:
Structural Studies on Membrane-Associate Cytochrome B5 and P450 NMR
膜相关细胞色素 B5 和 P450 NMR 的结构研究
- 批准号:
8197110 - 财政年份:2009
- 资助金额:
$ 28.81万 - 项目类别:
相似国自然基金
耦合生物物理与生化地球化学过程的土地覆被变化多尺度气候效应研究
- 批准号:42371102
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
藻类微生物燃料电池CO2藻菌协同生化转化及阴极原位耦合光催化捕获
- 批准号:52306222
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
光合共生生物膜生化转化及共水热碳化过程多元多相传递理论及强化方法
- 批准号:52236009
- 批准年份:2022
- 资助金额:269 万元
- 项目类别:重点项目
力信号与生化信号协同调制免疫细胞两个关键界面过程的生物物理研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
基于化学衍生化-亲和吸附-质谱技术研究新生儿缺血缺氧性脑病预后生物标志物
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
相似海外基金
Mitochondrial mechanisms and signaling in manganese exposure
锰暴露中的线粒体机制和信号传导
- 批准号:
10734614 - 财政年份:2023
- 资助金额:
$ 28.81万 - 项目类别:
Sestrins-mediated integration of leucine and exercise benefits for mitochondrial homeostasis
Sestrins介导的亮氨酸整合和运动对线粒体稳态的益处
- 批准号:
10734830 - 财政年份:2023
- 资助金额:
$ 28.81万 - 项目类别:
Novel unconventional myosins in B cell homeostasis
B 细胞稳态中的新型非常规肌球蛋白
- 批准号:
10733725 - 财政年份:2023
- 资助金额:
$ 28.81万 - 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 28.81万 - 项目类别: